Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 27.73% is 16% below its 5-year average of 33.08%, near the low end of its 5-year range (23.54%–39.42%).
2.16% below its 12-month average of 28.34%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-06-30): 35.22%.
GROSS MARGIN
27.73%
GROSS MARGIN AVG TTM
28.34%
GROSS MARGIN AVG 3Y
30.80%
GROSS MARGIN AVG 5Y
33.08%
GROSS MARGIN AVG 10Y
36.57%
GROSS MARGIN AVG 15Y
36.69%
GROSS MARGIN AVG 20Y
38.69%
CURRENT VS TTM AVG
-2.16%
CURRENT VS 3Y AVG
-9.96%
CURRENT VS 5Y AVG
-16.16%
CURRENT VS 10Y AVG
-24.18%
CURRENT VS 15Y AVG
-24.42%
CURRENT VS 20Y AVG
-28.32%
SECTOR MEDIAN · HEALTHCARE
39.32%
median of 679 covered companies
CURRENT VS SECTOR MEDIAN
-29.48%
vs the sector median at left
Accuray Incorporated
Market Cap
$34.48M
Gross Margin
27.73%
TTM Avg
28.34%
3Y Avg
30.80%
5Y Avg
33.08%
Market Cap
$34.34M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
10.20%
Market Cap
$34.04M
Gross Margin
57.46%
TTM Avg
78.73%
3Y Avg
89.36%
5Y Avg
76.24%
Market Cap
$35.15M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$32.76M
Gross Margin
41.73%
TTM Avg
31.44%
3Y Avg
27.18%
5Y Avg
29.99%
Market Cap
$36.80M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
22.09%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Accuray Incorporated (ARAY) | $34.48M | 27.73% | 28.34% | 30.80% | 33.08% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.34M | 0.00% | 0.00% | 0.00% | 10.20% |
| Elutia Inc (ELUT)vs › | $36.25M | 57.82% | 48.80% | 47.77% | 46.56% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $34.04M | 57.46% | 78.73% | 89.36% | 76.24% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| HeartBeam, Inc. (BEAT)vs › | $33.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| DocGo Inc. (DCGO)vs › | $35.76M | 30.12% | 32.64% | 32.93% | 33.24% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | 41.73% | 31.44% | 27.18% | 29.99% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.80M | 0.00% | 0.00% | 0.00% | 22.09% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.44M | 83.79% | 85.97% | 84.60% | 84.69% |
Gross Margin
27.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 35.22% |
| 2026-03-31 | 24.13% |
| 2025-12-31 | 23.54% |
| 2025-09-30 | 28.26% |
| 2025-06-30 | 30.56% |
| 2025-03-31 | 27.93% |
| 2024-12-31 | 36.06% |
| 2024-09-30 | 33.94% |
| 2024-06-30 | 28.63% |
| 2024-03-31 | 28.75% |
| 2023-12-31 | 33.48% |
| 2023-09-30 | 38.01% |
| 2023-06-30 | 31.85% |
| 2023-03-31 | 32.80% |
| 2022-12-31 | 37.44% |
| 2022-09-30 | 35.85% |
| 2022-06-30 | 39.10% |
| 2022-03-31 | 36.17% |
| 2021-12-31 | 36.66% |
| 2021-09-30 | 36.79% |
| 2021-06-30 | 39.42% |
| 2021-03-31 | 38.55% |
| 2020-12-31 | 41.90% |
| 2020-09-30 | 41.49% |
| 2020-06-30 | 41.85% |
| 2020-03-31 | 39.31% |
| 2019-12-31 | 38.35% |
| 2019-09-30 | 36.78% |
| 2019-06-30 | 39.11% |
| 2019-03-31 | 39.20% |
| 2018-12-31 | 37.51% |
| 2018-09-30 | 39.53% |
| 2018-06-30 | 42.17% |
| 2018-03-31 | 36.31% |
| 2017-12-31 | 39.23% |
| 2017-09-30 | 41.90% |
| 2017-06-30 | 38.53% |
| 2017-03-31 | 36.40% |
| 2016-12-31 | 35.87% |
| 2016-09-30 | 36.23% |
| 2016-06-30 | 39.27% |
| 2016-03-31 | 42.69% |
| 2015-12-31 | 39.09% |
| 2015-09-30 | 37.82% |
| 2015-06-30 | 39.76% |
| 2015-03-31 | 39.65% |
| 2014-12-31 | 39.21% |
| 2014-09-30 | 33.75% |
| 2014-06-30 | 37.69% |
| 2014-03-31 | 40.87% |
| 2013-12-31 | 40.77% |
| 2013-09-30 | 34.55% |
| 2013-06-30 | 32.14% |
| 2013-03-31 | 28.43% |
| 2012-12-31 | 34.23% |
| 2012-09-30 | 28.61% |
| 2012-06-30 | 36.30% |
| 2012-03-31 | 35.47% |
| 2011-12-31 | 37.81% |
| 2011-09-30 | 24.32% |
| 2011-06-30 | 42.84% |
| 2011-03-31 | 49.89% |
| 2010-12-31 | 54.32% |
| 2010-09-30 | 47.91% |
| 2010-06-30 | 50.27% |
| 2010-03-31 | 48.86% |
| 2009-12-31 | 45.30% |
| 2009-09-30 | 42.75% |
| 2009-06-27 | 46.07% |
| 2009-03-28 | 49.53% |
| 2008-12-27 | 51.02% |
| 2008-09-27 | 50.90% |
| 2008-06-28 | 52.80% |
| 2008-03-29 | 44.73% |
| 2007-12-29 | 53.54% |
| 2007-09-29 | 53.26% |
| 2007-06-30 | 56.63% |
| 2007-03-31 | 56.56% |
| 2006-12-30 | 55.80% |
| 2006-09-30 | 58.90% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
